16.19 USD
↗ 0.06 (0.37%)PRE MARKET (AS OF 06:29 AM EDT)
Aurinia Pharmaceuticals Inc
AUPHNASDAQ • USD
Market: OPEN
Aurinia Pharmaceuticals Inc (AUPH) is currently trading at $16.19. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Buy" and "Strong Buy" respectively. Notable factors include a robust Altman Z-Score, a strong Piotroski F-Score of 7/9, exceptional Return on Equity (51.1%), a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place AUPH at a fair price relative to peers.
Technical & fundamental data as of Sep 15, 2026.
Open?$16.19
High?$16.19
Low?$16.19
Prev. Close?$16.13
Volume?141
Avg. Volume?1.0M
VWAP?$16.19
Rel. Volume?0.00x
Bid / Ask
Bid?$14.00 × 100
Ask?$18.76 × 100
Spread?$4.76
Midpoint?$16.38
Valuation & Ratios
Market Cap?2.1B
Shares Out?133.1M
Float?103.0M
Float %?79.2%
P/E Ratio?6.83
P/B Ratio?3.49
EPS?$2.36
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
Themes
Employees
128
Market Cap
2.2B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2009-10-21
Address
#140, 14315 - 118 AVENUE
EDMONTON, A0 T5L 4S6
Phone: 250-744-2487
EDMONTON, A0 T5L 4S6
Phone: 250-744-2487
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookStrong Buy
Strong SellNeutralStrong Buy
F-Score?88
Z-Score?100
Momentum?90
Short Sent.?59
Piotroski F-Score?7/9Strong
Altman Z-Score?7.87Safe
Confidence?70%Moderate
Short InterestHigh
Short % of Float?8.72%Elevated
Short Interest?9.0M
Days to Cover?8.6
Free Float103.0M
Avg Daily Volume1.0M
Settlement Date2026-08-31
Financial Health
Current Ratio?5.42Strong
Quick Ratio?4.97Strong
Cash Ratio?1.80Strong
Debt/Equity?0.10Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score72/100
P/E?6.8CHEAP▾
Peers100
S&P97
P/B?3.49FAIR▾
Peers100
S&P49
P/S?6.89FAIR▾
Peers100
S&P18
P/FCF?12.3CHEAP▾
Peers100
S&P82
EV/EBITDA?13.0FAIR▾
Peers100
S&P62
EV/Sales?6.51HIGH▾
Peers100
S&P24
Returns & Efficiency
ROE?51.1%STRONG▾
Peers50
S&P91
ROA?39.7%STRONG▾
Peers50
S&P97
Cash Flow & Enterprise
FCF?$175.1M
Enterprise Value?$2.0B
Fundamentals ratios updated end of day